Prosecution Insights
Last updated: April 19, 2026

Examiner: JACKSON III, WALTER

Tech Center 1600 • Art Units: 1638 1675

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
7
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

5.0%
§101 Eligibility
20.0%
§102 Novelty
45.0%
§103 Obviousness
25.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18485192 METHODS AND DEVICES FOR GENERATING EMBRYOS IN VITRO FROM EMBRYONIC STEM CELLS Non-Final OA Cambridge Enterprise Limited
18503100 COMPOSITIONS AND METHODS FOR MAKING PARASYMPATHETIC NEURONS Non-Final OA University of Georgia Research Foundation, Inc.
18562068 ONCOLYTIC VIRUS BASED CANCER THERAPY Non-Final OA The Penn State Research Foundation
18498404 Cofactors FAD and PLP for Promoting Pancreatic Progenitors in Pancreatic Development Non-Final OA Qatar Foundation for Education, Science and Community Development
18568764 LIVER ORGANOID MODEL FOR HYPERBILIRUBINEMIA AND METHODS OF MAKING AND USING SAME Non-Final OA CHILDREN’S HOSPITAL MEDICAL CENTER
18289557 METHODS FOR STIMULATING AND TRANSDUCING T CELLS Non-Final OA C3S2 GMBH
18251030 Modified Red Blood Cells and Uses Thereof for Delivering Agents Non-Final OA Westlake Therapeutics (Hangzhou) Co. Limited

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month